柏林非住院COVID-19病例症状持续时间与60天临床病程的纵向研究
该研究对2020年3月至5月柏林102例居家隔离的实验室确诊COVID-19病例进行电话随访,收集25种症状在起病后前2周每日及第30天、第60天的出现情况与持续时间。结果显示不适、头痛和鼻炎最常见,41%和20%的患者在第30天和第60天仍有症状。
要点
- 非住院COVID-19患者中相当比例症状持续至少2个月。
- 前2周最常见症状为不适、头痛和鼻炎。
- 嗅觉障碍和味觉障碍多出现在第二周。
核心结论
- 相当比例的非住院COVID-19病例症状持续至少2个月。
- 需进一步研究评估非住院COVID-19患者长期不良健康效应的发生频率。
研究设计与样本
- 2020年3月至5月在德国柏林采用全人群抽样纳入102例居家隔离的实验室确诊COVID-19病例。
- 通过电话咨询(最多4次)收集25种症状的数据。
- 收集中位年龄35岁(范围18-74),57%(58/102)为女性,37%(38/102)报告有合并症。
主要发现
- 起病后前2周最常见症状为不适(94%,92/98)、头痛(71%,70/98)和鼻炎(69%,68/98)。
- 不适的中位持续时间为11天(IQR 7-14天),35%(34/98)的病例在第14天仍报告不适。
- 头痛和肌肉疼痛多发生在第一周,而嗅觉障碍和味觉障碍多发生在第二周。
- 第30天和第60天分别有41%(39/95)和20%(18/88)的患者症状持续。
临床怎么用
- 对非住院COVID-19患者应关注症状的长期持续,尤其是不适、嗅觉和味觉障碍。
- 随访中需评估第30天和第60天仍存在的症状,识别需要进一步健康干预者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundDetailed information on symptom duration and temporal course of patients with mild COVID-19 was scarce at the beginning of the COVID-19 pandemic.AimWe aimed to determine the longitudinal course of clinical symptoms in non-hospitalised COVID-19 patients in Berlin, Germany.MethodsBetween March and May 2020, 102 confirmed COVID-19 cases in home isolation notified in Berlin, Germany, were sampled using total population sampling. Data on 25 symptoms were collected during telephone consultations (a maximum of four consultations) with each patient. We collected information on prevalence and duration of symptoms for each day of the first 2 weeks after symptom onset and for day 30 and 60 after symptom onset.ResultsMedian age was 35 years (range 18-74), 57% (58/102) were female, and 37% (38/102) reported having comorbidities. During the first 2 weeks, most common symptoms were malaise (94%, 92/98), headache (71%, 70/98), and rhinitis (69%, 68/98). Malaise was present for a median of 11 days (IQR 7-14 days) with 35% (34/98) of cases still reporting malaise on day 14. Headache and muscle pain mostly occurred during the first week, whereas dysosmia and dysgeusia mostly occurred during the second week. Symptoms persisted in 41% (39/95) and 20% (18/88) of patients on day 30 and 60, respectively.ConclusionOur study shows that a significant proportion of non-hospitalised COVID-19 cases endured symptoms for at least 2 months. Further research is needed to assess the frequency of long-term adverse health effects in non-hospitalised COVID-19 patients.
引用
- Saad NJ, Moek F, Steitz F, et al. A longitudinal study on symptom duration and 60-day clinical course in non-hospitalised COVID-19 cases in Berlin, Germany, March to May, 2020. Euro Surveill. 2021. PMID: 34713798. doi:10.2807/1560-7917.ES.2021.26.43.2001757
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。